Revvity (RVTY) Research & Development (2009 - 2026)

Revvity (RVTY) has reported Research & Development for 18 consecutive years, with $49.0 million the latest figure, recorded in Q3 2026.

• For the quarter ending Q3 2026, Research & Development fell 8.06% year-over-year to $49.0 million; the trailing twelve-month figure through Jul 2026 stood at $215.8 million (up 5.17% YoY), and the FY2025 full-year result was $215.8 million, up 9.65% from the prior year.
• Research & Development slipped to $49.0 million in Q3 2026 per RVTY's latest filing, from $57.9 million in the prior quarter.
• Across five years, Research & Development topped out at $81.9 million in Q1 2023 and bottomed at $48.1 million in Q2 2024.
• Historically, Research & Development has averaged $54.7 million across 5 years, with a median of $53.4 million in 2022.
• The sharpest annual moves came in 2023 and 2025: Research & Development sank 39.42% in 2023, then climbed 18.22% in 2025.
• Over 5 years, Research & Development stood at $53.5 million in 2022, then fell by 7.33% to $49.6 million in 2023, then decreased by 0.78% to $49.2 million in 2024, then climbed by 18.22% to $58.2 million in 2025, then decreased by 15.82% to $49.0 million in 2026.
• According to Business Quant data, Research & Development over the past three periods registered $49.0 million, $57.9 million, and $58.2 million for Q3 2026, Q2 2026, and Q4 2025 respectively.